PA-GROVARA
19.5.2022 13:02:12 CEST | Business Wire | Press release
Grovara , the easy global wholesale experience, announces it has signed a lease agreement and become formally incorporated to do business in Dubai as part of a partnership with Dubai Global Connect (DGC) , a permanent wholesale market that facilitates business between international buyers and sellers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220519005017/en/
The partnership will integrate Grovara’s first-to-market digital global trading platform with DGC’s one-of-a-kind physical marketplace, providing unprecedented speed, reliability, and growth potential for DGC’s global wholesale buyers and sellers.
Grovara will leverage its international B2B online marketplace with DGC’s state-of-the-art showroom ecosystem for wholesale food, home furnishings, and fashion trade to supercharge CPG brands’ global distribution. Grovara’s digital platform streamlines and automates global wholesale trade, enabling buyers to find and manage suppliers and sellers while showcasing and selling goods online and managing fulfillment.
“The future of trade is digital, with a human touch. Our game-changing global marketplace will help bring Dubai Global Connect’s community of brands and buyers online,” says Grovara Co-Founder and CEO Abu Kamara. “Our technology is a turbo booster for international trade, and coupled with DGC’s state-of-the-art, bespoke physical showroom marketplace, Dubai is ready to be the launch pad.”
DGC’s facility will be one of the highlights of fast-growing Dubai South, the largest single urban master development in Dubai. Dubai South is being developed as an aviation and logistics ecosystem including a multi-modal transport infrastructure connecting air, land, and sea, and planned residential and commercial developments. DGC is located between Al Maktoum International Airport, which will be the world’s largest airport when construction is complete, and Jebel Ali Port, the Middle East’s busiest port.
With 2.5 billion people within a four-hour flight and 5 billion within an eight-hour flight, Dubai is globally recognized as an ideal place to live, work and play, while also offering transparent, business-friendly free-zone regulation across the country. The Dubai South Free Zone fosters ingenuity, offers ease of doing business, and provides comprehensive services that enable 100% foreign ownership and income and personal tax exemption.
Grovara will be the digital global wholesale option for those new businesses looking for buyers and sellers, with easy discovery, pricing, and purchasing that saves time and cost while delivering better performance via a curated marketplace. Sellers rely on Grovara’s automated export and operations document managers and achieve faster sales and brand valuations by selling to more customers.
“Our technology and in-country expertise will make it even easier for buyers and sellers from across the entire region to meet halfway in Dubai, where they’ll find all the support they need to grow,” says Grovara Sales Director Eugenia Schlitter.
DGC offers a number of physical spaces and services for brands and buyers, like showrooms, boutique offices, secure self-storage units with direct access to showrooms, and a smart service center offering a one-stop shop for a variety of business services. DGC is also planning a lavish auditorium, innovation hub, entrepreneurship center, and a year-round program of industry-specific programming.
“We are pleased to welcome Grovara to the Dubai Global Connect community here in Dubai,” says DGC’s Head of Business Development Paul Boots. “Grovara will be able to tap into DGC’s year-round physical showroom ecosystem and showcase some of the great brands available on their platform.
“Dubai is the natural gateway to the emerging markets, and the combination of Grovara and DGC will enable brands to expand their reach to a global buying audience, through Dubai. Partnerships such as these will further support DGC’s ambition to make Dubai a place of reference for the international B2B food trade, and we look forward to supporting them with the growth of their business.”
ABOUT GROVARA
Grovara enables an easy global wholesale experience as the first-to-market online marketplace supporting thousands of CPG products for export/import in more than 50 countries. With offices in Philadelphia, Mexico, and Dubai, Grovara facilitates global exporting and importing with a lightweight, tech-driven platform that provides automation and intelligence-based tools. Grovara leverages visibility, discovery, and an intuitive user experience to deliver easy transacting and management, creating a streamlined pathway to dynamic global growth potential. For more information or to join the curated ecosystem, please visit Grovara.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220519005017/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 14:23:00 CEST | Press release
–Late-Breaking Prespecified Subgroup Analysis of HELIOS-B Demonstrates that Vutrisiran Provided Consistent Clinical Benefit Across All-Cause Mortality and Recurrent Cardiovascular Events in Patients With or Without Tafamidis Use at Baseline ––Additional Post Hoc Analyses Highlight Positive Impact of Vutrisiran in Addressing the Multisystemic Manifestations of ATTR-CM ––Pooled Analysis Across Four Positive Phase 3 Studies of Vutrisiran and Patisiran Shows Consistent Treatment Effect Across Sexes ––New Subgroup Analysis from KARDIA-3 Phase 2 Study of Zilebesiran Highlights Potential to Provide Enhanced Blood Pressure Control – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR)
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom